Biogen Inc (BIIB)
149.74
-0.16
(-0.11%)
USD |
NASDAQ |
Dec 27, 12:40
Biogen Research and Development Expense (Annual): 2.462B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly and Co | 9.313B |
| Pfizer Inc | 10.68B |
| Regeneron Pharmaceuticals Inc | 4.439B |
| Sage Therapeutics Inc | 356.24M |
| Moderna Inc | 4.845B |